Showing results (311-320 of 526) with videos related to
Sort By:
Pageof 53
Journal of Medical Imaging and Radiation Sciences|March 1, 2024
Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomesAnna Gullhaug, Vilde D Haakensen, Dirk De Ruysscher, et al.Acta Oncologica (Stockholm, Sweden)|February 21, 2019
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registriesCatherine E Mercado, William F Hartsell, Charles B Simone, et al.Blood|June 26, 2012
Radiation therapy for the management of patients with HTLV-1-associated adult T-cell leukemia/lymphomaCharles B Simone, John C Morris, Donn M Stewart, et al.Cancer|July 6, 2017
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancerJean-Claude M Rwigema, Vivek Verma, Liyong Lin, et al.Medical Physics|August 5, 2022
Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapyShouyi Wei, Haibo Lin, Chengyu Shi, et al.Cancers|February 24, 2024
Pencil Beam Scanning Proton Bragg Peak Conformal FLASH in Prostate Cancer Stereotactic Body RadiotherapyTyler Kaulfers, Grant Lattery, Chingyun Cheng, et al.The Annals of Thoracic Surgery|November 10, 2016
Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three YearsJoseph S Friedberg, Charles B Simone, Melissa J Culligan, et al.Cureus|March 12, 2026
Challenges and Opportunities in Evaluating Novel Drug-Radiotherapy CombinationsShelby Lane, Charles B Simone, Jessica Schuster, et al.Cureus|July 14, 2026
Proton Beam Therapy for Testicular Seminoma: Clinical Outcomes and Toxicity From the Proton Collaborative Group Prospective RegistryLifei Zhu, Keyur J Mehta, Charles B Simone, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2021
The Impact of Durvalumab on Local-Regional Control in Stage III NSCLCs Treated With Chemoradiation and on KEAP1-NFE2L2-Mutant TumorsNarek Shaverdian, Michael Offin, Annemarie F Shepherd, et al.Pageof 53